FeesSafety
Pluang+

INVE Technologies plans to buy back $20M in shares at $2.85 each via tender offer.

Company Fundamentals
20 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
INVE Technologies plans to buy back $20M in shares at $2.85 each via tender offer.

INVE Technologies announced preliminary results of its tender offer to repurchase up to $20 million of its common stock at $2.85 per share. Approximately 10.7 million shares were tendered, and the company expects to buy about 7.5 million shares, representing 31.4% of its outstanding shares, for a total cost of around $21.4 million. The final purchase details, including the exact number of shares and proration factor, will be confirmed after the guaranteed delivery period ends. This buyback reflects the company's strategy to return value to shareholders and manage its capital structure.

INVE Technologies announced a tender offer to repurchase up to $20 million of its common stock, expecting to buy about 31.4% of its outstanding shares. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 20, 2026 19:41 WIB: out of 150 priced US tech stocks, 21 rose and 129 fell. Notable movers include CLS at USD 226.50 with a 1-day change of -5.72% and 100% sell order activity, ARM at USD 167.50 down 5.46% with 69% sell orders, and DELL at USD 295.65 down 5.43% with a balanced buy/sell order split.

More News

TREMFYA shows significant improvement in spinal pain and inflammation in psoriatic arthritis patients in Phase 4 study

TREMFYA shows significant improvement in spinal pain and inflammation in psoriatic arthritis patients in Phase 4 study

Johnson & Johnson's TREMFYA (guselkumab) demonstrated significant improvements in spinal pain, stiffness, and MRI-confirmed inflammation in patients with axial psoriatic arthritis (PsA) in the Phase 4 STAR study. The study, the first of its kind usin...

Company Fundamentals
Bullish
48 minutes ago
Build a balanced portfolio with Vanguard Morningstar Growth ETF for growth and Schwab U.S. Dividend Equity ETF for income.

Build a balanced portfolio with Vanguard Morningstar Growth ETF for growth and Schwab U.S. Dividend Equity ETF for income.

Investors seeking both growth and income can consider a simple ETF portfolio combining the Vanguard Morningstar Growth ETF (VUG) and the Schwab U.S. Dividend Equity ETF (SCHD). VUG focuses on large-cap growth stocks, heavily weighted in technology, w...

Market News
Bullish
1 hour ago
Hyperliquid aims to become the Amazon of decentralized finance by scaling perpetual futures markets.

Hyperliquid aims to become the Amazon of decentralized finance by scaling perpetual futures markets.

Hyperliquid, a decentralized exchange specializing in perpetual futures contracts, is expanding its platform to include real-world assets and prediction markets, aiming to become the "house all of finance." It operates similarly to Amazon's marketpla...

Market News
Bullish
1 hour ago
Bitcoin plunges below $62,000 amid tech selloff, inflation fears, and largest crypto hack ever.

Bitcoin plunges below $62,000 amid tech selloff, inflation fears, and largest crypto hack ever.

Bitcoin has dropped below $62,000 after six consecutive weeks of decline, falling more than 50% from its October 2025 peak of around $126,000. The slide was triggered by a combination of factors including a tech sector selloff due to AI valuation con...

Bearish
1 hour ago
Rocket Lab beats sales estimates, backlog soars, and posts first positive operating cash flow quarter.

Rocket Lab beats sales estimates, backlog soars, and posts first positive operating cash flow quarter.

Rocket Lab reported Q3 sales of $268 million, beating estimates and marking a 73% year-over-year increase, with a backlog growing to $3.6 billion. Despite missing earnings expectations with a loss of $0.12 per share, the company achieved its first fu...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App